UEEC— United Health Products, Inc.

$0.06+7.54%

OTC

No insider trading activity on record for UEEC.

Price Chart

Loading…

Insider Transactions

No transactions found.

No recent congressional transactions.

Agency	Description	Amount	Period
Department of Defense	T3 MANAGED CARE SUPPORT CONTRACT FOR WEST REGION	$13.15B	Mar 2012 – Feb 2019
Department of Defense	IGF::CT::IGF EELV FY13 + PHASE I BUY	$9.50B	Jun 2013 – Dec 2022
Department of Defense	200610!000002!5700!FA8816!SMC/EVK !FA881606C0002 !A!N! !N! ! !20060228!20070930!926784042!834951691!834951691!N!LOCKHEED MARTIN CORPORATION !12257 HIGHWAY 121 !LITTLETON !CO!80125!45255!005!08!LITTLETON !ARAPAHOE !COLORADO !+000335912412!N!N!000815040082!1810!SPACE VEHICLES !A2 !MISSILE AND SPACE SYSTEMS !176 !EELV !336414!E! !3! ! ! ! ! !99990909!B! ! !A! !D!N!R!1!001!N!1G!Z!Y!Z! ! !N!C!N! ! ! !A!A!A!A!000!A!C!Y! ! ! !Y! ! !0001! !	$3.58B	Feb 2006 – Dec 2013
Department of Energy	OAK RIDGE RESERVATION CLEANUP CONTRACT TASK ORDERS	$2.41B	May 2023 – Feb 2032
Department of Defense	DELTA IV HEAVY LAUNCH SERVICES	$1.73B	Oct 2018 – Nov 2024
Department of Defense	BUY 3 BOEING LAUNCH SERVICES	$1.34B	Jun 2006 – Sep 2010

From USASpending.gov. Matched by company name keyword.

Revenue

—

Operating Income

-$2.3M

-12.3% YoY

Net Income

-$2.7M

-33.4% YoY

Free Cash Flow

-$1.2M

+0.7% YoY

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$0	$0	$0-100.0%	$38K+63459.3%	$59
Selling, general and administrative expenses	$2.0M+20.2%	$1.7M-9.6%	$1.8M-16.8%	$2.2M-92.6%	$29.6M
Research and development expenses	$270K-24.2%	$356K-40.6%	$599K-4.1%	$625K+163.0%	$237K
Total Operating Expenses	$2.3M+12.3%	$2.0M-17.3%	$2.4M-14.0%	$2.8M-90.5%	$29.8M
Loss from Operations	-$2.3M-12.3%	-$2.0M+17.3%	-$2.4M+13.4%	-$2.8M+90.6%	-$29.8M
Interest expense	-$113K-250.5%	-$32K+20.2%	-$41K-138.0%	-$17K+92.5%	-$226K
Interest expense - related party	-$87K-13.0%	-$77K-1.6%	-$76K-22.4%	-$62K+84.2%	-$392K
Gain (loss) on derivative liabilities	$28K	$0	—	—	—
Fraud loss	-$242K	$0	—	—	—
Gain (loss) on settlement of debt	$0-100.0%	$115K+242.9%	-$81K+61.6%	-$210K+51.8%	-$435K
Total Other Income (Expense)	-$414K-7188.1%	$6K+103.0%	-$197K-117.7%	$1.1M+248.9%	-$749K
Income tax expense	$0	$0	$0	$0	$0
Net Loss	-$2.7M-33.4%	-$2.0M+23.7%	-$2.6M-55.5%	-$1.7M+94.5%	-$30.5M
Basic and diluted	-$0.01+0.0%	-$0.01+0.0%	-$0.01+0.0%	-$0.01+92.9%	-$0.14
Weighted average number of shares outstanding	$257.0M+3.5%	$248.2M+3.8%	$239.1M+4.1%	$229.7M+1.8%	$225.7M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

United Health Products Provides Regulatory Update

United Health Products Provides Corporate Update

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th